TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MAZE

Maze Therapeutics, Inc.

Healthcare · Biotechnology · —

26.10$ -0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MAZE
Line item 2022 2023 2024 2025
0.00 0.00 3.82 0.00
0.09 0.09 0.08 0.06
-0.09 -0.09 3.82 -0.06
2.01 1.69 1.91 2.52
0.52 0.56 0.60 0.80
2.54 2.25 2.51 3.27
-2.54 -2.25 1.31 -3.33
-2.63 -2.29 1.22 -3.05
– – 0.03 –
-2.63 -2.29 1.19 -3.05
-2.54 -2.20 1.29 -3.00

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?